Podcasts We Liked
From Lagos to the Lab: How a UC San Diego Surgeon Is Reinventing Vascular Care, AI, and Medical Devices
“In this episode, Dr. Ross shows how seamlessly surgery, AI, and practical innovation can come together—precisely the kind of impact that moves our ecosystem forward.” —Robert Mowry, Partner, Del Mar Medical Pensions
Unlocking Life Science Innovation: Investor Reflections on Phase Two Ventures’ Journey
The recent interview on the “Bizzy Scientists” podcast, featuring Dr. Jose Morachis and Dr. Will Alaynick—the co-founders of Phase Two Ventures—serves as a masterclass in the art of turning scientific genius into investable opportunity, especially within the fertile grounds of San Diego’s innovation ecosystem.
The Mindset of a Modern Entrepreneur: Insights from UC San Diego’s Office of Innovation and Commercialization
Entrepreneurship is often glamorized as a bold leap into the unknown—a high-stakes game of risk, disruption, and hustle. But in a recent episode of the Bizzy Scientists podcast, hosted by Dr. Nora Saffran and produced in partnership with UC San Diego’s Office of Innovation and Commercialization and the Salomon Center for Entrepreneurship, a very differe…
From Physics to Innovation: Dr. Victoria Cajipe on Translating Research into Real-World Impact
In a recent episode of the Bizzy Scientist podcast, hosted by Dr. Nora Safa and produced by UC San Diego’s Office of Innovation and Commercialization, Dr. Victoria Cajipe shared a rare and inspiring journey—one that bridges fundamental physics research, startup grit, and the dynamic world of academic innovation. Now Associate Director of Technology Lice…
Pioneering Innovation: UC San Diego's Blueprint for Entrepreneurial Success
UC San Diego is a leader in driving innovation and nurturing entrepreneurial talent. Central to this mission is Dr. Paul Roben, Associate Vice Chancellor for Innovation and Commercialization, whose inspiring journey reflects the entrepreneurial spirit the university strives to foster.
A New Era for Biogen and LA Biotech: Christopher Viehbacher’s Vision at LABEST 2024
Biogen is shifting from its identity as an MS company toward bold leadership in immunology and rare diseases.
Biotech's Boldest Minds on Innovation, Immunology, and Cell Therapy
Cross-Disciplinary Scientists Are Driving the Future: All five panelists transitioned from academia to industry by focusing on patient impact, translational science, and innovation beyond their original expertise.
Biogen CEO Christopher Viehbacher at LABEST
Legacy and Leadership: Arie Belldegrun recounts a pivotal 2014 encounter with Christopher Viehbacher that highlighted both men's commitment to innovation over acquisition.
From Deep Freeze to Funding Thaw: Insights from Leaders in Life Science Venture Capital
At the 2024 LABEST conference hosted by UCLA Technology Development Group, a standout panel titled "The Latest Trends in Venture Capital Investing" brought together four distinguished investors navigating today’s uncertain biotech market. Moderated by Josh Green—former Chairman of the National Venture Capital Association and a double Bruin himself—the c…
Made in LA: Case Studies in Bio Success
At LABEST 2024, UCLA Technology Development Group brought together four innovative leaders shaping the biotech landscape in Los Angeles for a dynamic panel titled "Made in LA: Case Studies in Bio Success." Moderated by Amir Naiberg, Associate Vice Chancellor and CEO of UCLA TDG, the panel featured:
The Vision and Impact of the California Institute for Immunology and Immunotherapy at UCLA Research Park
Reimagining Medicine: The Vision and Impact of the California Institute for Immunology and Immunotherapy at UCLA Research Park
Women's Health Innovation and Equity at UCLA LABEST 2024
The UCLA LABEST 2024 panel on women’s health marked a seismic shift in how we research, diagnose, and treat conditions that disproportionately affect women. From the White House Initiative on Women’s Health Research to cutting-edge AI, chip technology, and stem cell advances, this session showcased how innovation is bridging centuries of gender bias in …
Slashing Cancer Deaths in Five Years: Dr. Marty Tenenbaum’s Bold Vision at UCLA LABEST 2024
At UCLA LABEST 2024, Dr. Marty Tenenbaum, Founder and Chairman of Cancer Commons, delivered a keynote that was both deeply personal and profoundly visionary. His central thesis: we can slash cancer mortality by 25% in five years—not by waiting for new drugs, which take a decade or more to develop—but by radically transforming how we match patients with …
Dean Kamen's Trailblazing Innovation at the Intersection of Medicine and Engineering
Three Decades, Three Missions
Dr. Jamie Justice on Prize-Driven Innovation: Advancing Healthspan and Ovarian Health
At the recent NextMed conference in Coronado, Jamie Justice—Executive Director of the XPRIZE Healthspan and Executive Vice President for Health at the XPRIZE Foundation—delivered a powerful and inspiring talk on how incentivized competition can transform the future of aging and women’s health. Drawing from her academic background in geriatrics and geron…
Lessons from Dr. Larry Brilliant on Smallpox, Global Health, and the Future
A Moment of Reflection on Eid and Doctor’s Day
Jamie Metzl on the Future of Healthcare: Superconvergence and the Human Imagination
From the Stars to the Clinic: Why Perspective Matters
Dr. Robert Green’s Vision for Genomic Medicine in Newborns: Turning Data into Diagnosis:
Dr. Robert Green, professor of genetics at Harvard Medical School, gave a landmark talk on making massive genomic datasets actionable—starting with newborns. While the idea of sequencing all newborns has existed for decades—since before the Human Genome Project began—it remains largely unimplemented in routine healthcare. Most U.S. hospitals still rely …
Dr. Rafael Grossman’s Vision for Extended Reality and AI in Surgery
Dr. Rafael Grossman, a pioneering surgeon and technology enthusiast, took the stage at a recent healthcare innovation conference to share his perspective on the intersection of surgery, immersive technologies, and artificial intelligence. Known as the first surgeon to use Google Glass during live surgery, Grossman has built a career at the crossroads of…
Dr. Michael Gillam’s Vision for Scaling Breakthroughs in Healthcare: From 17 Years to One Click
For decades, one statistic haunted healthcare innovators: it takes an average of 17 years for medical breakthroughs to reach widespread clinical adoption. Whether it’s a new treatment, a diagnostic method, or a preventative screening tool, the translation from proven science to routine care has always lagged—slow, inefficient, and obstructed by a comple…
Dr. René Caissie’s Vision for Agentic AI and the Future of Scientific Discovery: The Easy Button for Research
In a world where butter can apparently kill you—at least according to a widely publicized 2024 JAMA study—Dr. René Caissie, Stanford professor and founder of MetalLoop, challenges us to ask deeper questions. Not just about butter, but about how science is done, who gets to do it, and how artificial intelligence can radically reshape the future of resear…
Steve Brown’s Vision for Agentic AI in Healthcare: When the Patient Is the Technologist
Steve Brown never imagined he’d be back in healthcare. Twenty years ago, he helped pioneer remote patient monitoring—long before the term became a staple in digital health conversations. He built companies, spoke at conferences, and eventually sold his business, stepping away from a field he found inspiring but exhausting. “Healthcare takes forever and …
Dr. Anthony Chang’s Vision for Artificial Intelligence in Healthcare
At a time when the U.S. faces declining life expectancy and soaring healthcare costs, Dr. Anthony Chang delivered an urgent and energizing keynote at a recent health innovation conference. A pediatric cardiologist and Chief Intelligence and Innovation Officer at Children’s Hospital of Orange County, Dr. Chang is also the founder of AI Med and a thought …
The Future of Equitable Innovation in Healthcare: A Call to Action from Dr. Bayo Curry-Winchell
At a time of transformative potential in healthcare, it’s vital we ask ourselves not just what innovation can do, but whom it will serve. In a powerful and urgent speech, Dr. Bayo Curry-Winchell, president of the Commonwealth Fund and a practicing primary care physician, laid out a compelling blueprint for equitable innovation in healthcare. Speaking fr…
The Future of Health Is Now: Dr. Daniel Kraft’s Vision at NextMed Health 2025
At the historic Hotel Del Coronado, leaders in health innovation gathered for this year’s NextMed Health conference. But no facelift was more transformative than the one unfolding in real time inside the ballroom, where Dr. Daniel Kraft, physician-scientist, innovator, and founder of NextMed Health, took the stage to paint a thrilling portrait of medici…